101 related articles for article (PubMed ID: 11506919)
21. A polyclonal human IgG preparation hyperimmune for type III, group B Streptococcus: in vitro opsonophagocytic activity and efficacy in experimental models.
Givner LB; Edwards MS; Baker CJ
J Infect Dis; 1988 Oct; 158(4):724-30. PubMed ID: 3049837
[TBL] [Abstract][Full Text] [Related]
22. Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.
Yang HH; Madoff LC; Guttormsen HK; Liu YD; Paoletti LC
Infect Immun; 2007 Jul; 75(7):3455-61. PubMed ID: 17470542
[TBL] [Abstract][Full Text] [Related]
23. Seroepidemiology of group B streptococcus type III colonization at delivery.
Gray BM; Pritchard DG; Dillon HC
J Infect Dis; 1989 Jun; 159(6):1139-42. PubMed ID: 2656881
[No Abstract] [Full Text] [Related]
24. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate.
Davies HD; Adair C; McGeer A; Ma D; Robertson S; Mucenski M; Kowalsky L; Tyrell G; Baker CJ
J Infect Dis; 2001 Aug; 184(3):285-91. PubMed ID: 11443553
[TBL] [Abstract][Full Text] [Related]
25. [Type-specific antibody to type Ia, Ib, II and III group B Streptococcus in maternal and neonatal sera measured by ELISA].
Sugiyama M; Kojima M; Hori Y; Simizu S; Sugiyama A; Ooe Y; Nishiyama Y
Kansenshogaku Zasshi; 1990 Sep; 64(9):1232-8. PubMed ID: 2243195
[TBL] [Abstract][Full Text] [Related]
26. Seroepidemiological studies of group B Streptococcus type II.
Gray BM; Pritchard DG; Dillon HC
J Infect Dis; 1985 Jun; 151(6):1073-80. PubMed ID: 2582066
[TBL] [Abstract][Full Text] [Related]
27. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood.
Santi I; Scarselli M; Mariani M; Pezzicoli A; Masignani V; Taddei A; Grandi G; Telford JL; Soriani M
Mol Microbiol; 2007 Feb; 63(3):754-67. PubMed ID: 17212592
[TBL] [Abstract][Full Text] [Related]
28. Protective efficacy against group B streptococcal infection in neonatal mice delivered from preimmunized pregnants.
Itoh T; Yan XJ; Nakano H; Yoshioka M
Microbiol Immunol; 1986; 30(4):297-305. PubMed ID: 3523166
[TBL] [Abstract][Full Text] [Related]
29. Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate.
Paoletti LC; Pinel J; Kennedy RC; Kasper DL
J Infect Dis; 2000 Feb; 181(2):653-8. PubMed ID: 10669351
[TBL] [Abstract][Full Text] [Related]
30. Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections.
Dangor Z; Lala SG; Kwatra G; Madhi SA
Curr Opin Infect Dis; 2016 Jun; 29(3):262-7. PubMed ID: 26926474
[TBL] [Abstract][Full Text] [Related]
31. Human antibody to the group-specific polysaccharide of group B Streptococcus.
Anthony BF; Concepcion NF; Concepcion KF
J Infect Dis; 1985 Feb; 151(2):221-6. PubMed ID: 3881538
[TBL] [Abstract][Full Text] [Related]
32. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody.
Kim KS; Wass CA; Hong JK; Concepcion NF; Anthony BF
Pediatr Res; 1988 Nov; 24(5):628-32. PubMed ID: 3060825
[TBL] [Abstract][Full Text] [Related]
33. Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum.
Lachenauer CS; Baker CJ; Baron MJ; Kasper DL; Gravekamp C; Madoff LC
J Infect Dis; 2002 Feb; 185(3):368-74. PubMed ID: 11807719
[TBL] [Abstract][Full Text] [Related]
34. Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants.
Dangor Z; Kwatra G; Izu A; Adrian P; Cutland CL; Velaphi S; Ballot D; Reubenson G; Zell ER; Lala SG; Madhi SA
Expert Rev Vaccines; 2015; 14(12):1651-60. PubMed ID: 26364978
[TBL] [Abstract][Full Text] [Related]
35. Antibody to type III group B Streptococcus in the rhesus monkey.
Larsen JW; Harper JS; London WT; Baker CJ; Curfman BL; Kasper DL; Sever JL
Am J Obstet Gynecol; 1983 Aug; 146(8):958-62. PubMed ID: 6349364
[TBL] [Abstract][Full Text] [Related]
36. Intrapulmonary bacterial clearance of type III group B streptococcus is reduced in preterm compared with term rabbits and occurs independent of antibody.
Hall SL; Sherman MP
Am Rev Respir Dis; 1992 May; 145(5):1172-7. PubMed ID: 1586063
[TBL] [Abstract][Full Text] [Related]
37. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein.
Madoff LC; Michel JL; Gong EW; Rodewald AK; Kasper DL
Infect Immun; 1992 Dec; 60(12):4989-94. PubMed ID: 1452329
[TBL] [Abstract][Full Text] [Related]
38. Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons.
Edwards MS; Rench MA; Palazzi DL; Baker CJ
Clin Infect Dis; 2005 Feb; 40(3):352-7. PubMed ID: 15668856
[TBL] [Abstract][Full Text] [Related]
39. Immune Responses to Invasive Group B Streptococcal Disease in Adults.
Edwards MS; Rench MA; Rinaudo CD; Fabbrini M; Tuscano G; Buffi G; Bartolini E; Bonacci S; Baker CJ; Margarit I
Emerg Infect Dis; 2016 Nov; 22(11):1877-1883. PubMed ID: 27767008
[TBL] [Abstract][Full Text] [Related]
40. Protective immunization in mice against group B streptococci using encapsulated C5a peptidase.
Santillan DA; Andracki ME; Hunter SK
Am J Obstet Gynecol; 2008 Jan; 198(1):114.e1-6. PubMed ID: 17905172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
